Radiation

Ishwaria M. Subbiah, MD, MS, FASCO, is a third-generation health care professional and second-generation medical oncologist.

The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, early-stage cervical cancer who underwent radical hysterectomy, according to randomized phase 3 study results.

PD-1 blockade conferred benefit to certain women with surgically resectable endometrial cancer, findings presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer showed.

Integrating structured patient-provider conversations about costs into the shared decision-making model of cancer care may help identify financial toxicity and allow for early intervention, according to a review in JCO Oncology Practice.

A five-factor risk model effectively predicted 2-year lymphedema-free survival among a cohort of patients with breast cancer, according to findings published in JAMA Network Open.

An American College of Surgeons initiative reduced postoperative hospitalization among older adults with cancer, according to study findings.

World Cancer Day will be observed Feb. 4.

Offering image-guided superficial radiation therapy to rural populations could mend health disparities in nonmelanoma skin cancer treatment, according to a study published in Cancers.

An analysis of adults with malignant glioma revealed that men were diagnosed at a younger age and women had worse preoperative status, but researchers found no other sex-related differences or clinical advantage.

An American Society of Radiation Oncology survey has shined a spotlight on the impact prior authorization has on providers and patients.